The International Vaccine Institute (IVI) is a nonprofit international organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.
Created initially as an initiative of the United Nations Development Programme (UNDP), IVI began formal operations as an independent international organization in 1997 in Seoul, Republic of Korea. Currently, IVI has 35 countries and the World Health Organization (WHO) as signatories and/or state parties to its Establishment Agreement. The Institute has a unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions.
Follow us on Twitter: @IVIHeadquarters
Follow us on YouTube: http://www.youtube.com/channel/UCpx8PUK9VD2Nppwrs_pWQcg
Read updates from us on Happy Bean: http://happylog.naver.com/ivilove.do
Read updates from us on Naver:
http://blog.naver.com/iviheadquart/
한국어: http://www.facebook.com/samthesciencebear
Donate to IVI: http://220.93.120.115/web/www/09_01
Created initially as an initiative of the United Nations Development Programme (UNDP), IVI began formal operations as an independent international organization in 1997 in Seoul, Republic of Korea. Currently, IVI has 35 countries and the World Health Organization (WHO) as signatories and/or state parties to its Establishment Agreement. The Institute has a unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions.
Follow us on Twitter: @IVIHeadquarters
Follow us on YouTube: http://www.youtube.com/channel/UCpx8PUK9VD2Nppwrs_pWQcg
Read updates from us on Happy Bean: http://happylog.naver.com/ivilove.do
Read updates from us on Naver:
http://blog.naver.com/iviheadquart/
한국어: http://www.facebook.com/samthesciencebear
Donate to IVI: http://220.93.120.115/web/www/09_01
Location: Spain, Valencian Community, Valencia
Employees: 51-200
Phone: +82 2-872-2801
Founded date: 1997
Mentions in press and media 13
| Date | Title | Description |
| 11.07.2025 | Bio Investments Group (BIG) and International Vaccine Institute (IVI) Forge Partnership to Accelerate Vaccine Self-Reliance in Africa and the Middle East | ZUG, Switzerland and SEOUL, July 11, 2025 /PRNewswire/ -- The Bio Investments Group AG (BIG), a leading global healthcare-technology transfer platform, and the International Vaccine Institute (IVI), an international organization dedicated t... |
| 25.01.2023 | IVI opens Country Office in Austria | SEOUL, South Korea, Jan. 25, 2023 /PRNewswire/ -- The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announce... |
| 27.09.2022 | IVI’s 21st International Vaccinology Course highlights breakthroughs in vaccine science and technology | IVI's 21st International Vaccinology Course kicks off from two locations: IVI HQ in Seoul and the Karolinska Institutet in Stockholm. This year’s course will host 200 trainees at IVI headquarters in Seoul and 20 at Karolinska Institutet in ... |
| 30.08.2022 | Danish Minister for Health visits the International Vaccine Institute during official visit to Republic of Korea | Dr. Jerome Kim, Director General of IVI (left), and H.E. Magnus Heunicke, Minister for Health of Denmark (right), meet at IVI headquarters during the Minister's official visit to the ROK. Dr. Jerome Kim, Director General of IVI, H.E. Magnus... |
| 29.07.2022 | Introductory Course for Biologics Development and Manufacturing completes training of 138 participants from 25 countries | 138 trainees from 25 countries completed the 2022 Introductory Course for Biologics Development and Manufacturing, the first course of the Global Training Hub for Biomanufacturing initiative. SEOUL, REPUBLIC OF KOREA, July 29, 2022 /EINPres... |
| 20.07.2022 | IVI and Moderna sign memorandum of understanding for vaccine research and development | Dr. Jerome Kim, Director General of IVI, and Dr. Paul Burton, Chief Medical Officer of Moderna, exchange a memorandum of understanding for R&D collaboration at IVI headquarters in Seoul, Korea on July 20, 2022. A delegation from Moderna... |
| 20.06.2022 | Spain joins IVI with flag-raising ceremony | His Excellency Juan Ignacio Morro, Ambassador of the Kingdom of Spain to the Republic of Korea, raises the Spanish flag at IVI headquarters today during the accession ceremony. Spain joined IVI, an international organization with a mission ... |
| 06.05.2022 | IVI, SmileGate, partners team up to vaccinate 28,000 people in Nepal | A child receives oral cholera vaccine (OCV) during a vaccination campaign in Rupani, Nepal. Children in line to receive oral cholera vaccine (OCV) at a vaccination site in Rupani rural municipality in Nepal on May 1, 2022. The vaccination c... |
| 25.04.2022 | 2022 IVI-SK bioscience Park MahnHoon Award Ceremony honors Dr. Tore Godal, Profs. Drew Weissman & Katalin Karikó | IVI hosts the first annual IVI-SK bioscience Park MahnHoon Award Ceremony at its headquarters. Dr. Tore Godal attended the ceremony in person. From left to right: H.E. Frode Solberg, Norwegian Ambassador to Korea; H.E. Ban Ki-moon, 8th UN S... |
| 20.04.2022 | International Vaccine Institute appoints two members to its Board of Trustees representing Ecuador and Rwanda | Dr. Ximena Garzón Villalba, MD, PhD, Minister of Public Health, Government of Ecuador Dr. Leon Mutesa, MD, PhD, Professor of Human Genetics, University of Rwanda SEOUL, REPUBLIC OF KOREA, April 20, 2022 /EINPresswire.com/ -- The Internation... |
Show more